Clinical Trial

Photobiomodulation Therapy Plus M-health in Head and Neck Cancer Patients: LAXER Study

Study acronym: LAXER
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 5, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
The Photobiomodulation therapy could have positive effects on quality of life and oral health in head and neck cancer survivors post-radiotherapy. The improvement in quality of life will be maintained after a follow-up period.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2021-10-22; most recent amendment 2025-12-30.
Status change: Active, Not Recruiting → Recruiting 2023-06-01
Trial Details
NCT Number NCT05106608
Lead Sponsor Universidad de Granada
Conditions Head and Neck Cancer, Head and Neck Neoplasms, Xerostomia
Enrollment 60 participants
Start Date 2022-07-13
Primary Completion 2026-07 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-05